Xavier Fournie

Biography

Dr. Xavier Fournie has held various posts in different companies of the Mapi Group since 1986. These posts include, but are not limited to: project management in market research and clinical research; leading of clinical operations; general management of central lab activities; medical direction; Quality Assurance and Regulatory Affairs direction; and pharmacovigilance management. From 2001 to 2008, Dr. Fournie led the development of an independent unit within Mapi Group, ProClinica, dedicated to multi-country direct-to-patient contact management for proactive PRO data collection and patient assistance in studies. As the Mapi Group Corporate Medical Director since January 2008 and the Executive Vice President of Mapi Real World Evidence since 2009, Dr. Fournie has been in charge of the development and maintenance of professional relationships with a variety of audiences, including medical/scientific communities, health authorities, patient advocacy groups, and Industry leaders. He also oversees medical monitoring services, and develops a culture of ethical and regulatory compliance throughout the Mapi business units. He provides input to successfully bridge the gap between the clinical, commercial, and legal units while helping to develop and implement new services and strategic plans into Mapi Group. For four years, Dr. Fournie has practiced as a GP in hospitals and private practices within France and Germany. He is a member of the ENCePP working Group 1 “Research Standards and Guidances’ and the French and European CRO Federations (AFCROs / EUCROF. He has additional qualifications in Medical Law (Forensic Medicine), Sports Medicine, and Aviation Medicine.

Research Interest

clinical research